Price $188.30 |
Market Cap
74.65B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
32.4
|
P/B
3.24
|
P/S
3.78
|
Dividend %
0.30%
|
|
P/CF
-
|
P/FCF
29.6
|
Op. Cash Flow
3.12M
|
FCF
6.2
|
|
Op. Margin
13.90%
|
Net Margin
11.80%
|
ROE
10.40%
|
ROI
6.40%
|
|
ROA
4.90%
|
EPS Growth
14.80%
|
Current Ratio
1.4
|
Debt/Equity
71.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CRYO-CELL International, Inc. (CCEL) | $6.75 | - | - | 47.9M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.76 | - | - | 12.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
